Skip to main content

Guido Ferrari

Professor in Surgery
Surgery, Surgical Sciences
Box 2926 Med Ctr, Durham, NC 27710
915 S. LaSalle Street, SORF Building Room 208, Durham, NC 27710
Office hours Monday-Friday 08:00-18:00
Saturday and Sunday upon request  

Overview


The activities of the Ferrari Laboratory are based on both independent basic research and immune monitoring studies. The research revolves around three main areas of interest: class I-mediated cytotoxic CD8+ T cell responses, antibody-dependent cellular cytotoxicity (ADCC), gene expression in NK and T cellular subsets upon infection with HIV-1. With continuous funding over the last 11 years from the NIH and Bill & Melinda Gates Foundation along with many other productive collaborations within and outside of Duke, the Ferrari Lab has expanded its focus of research to include the ontogeny of HIV-1 specific immune responses that work by eliminating HIV-1 infected cells and how these can be induced by AIDS vaccine candidates.

Current Appointments & Affiliations


Professor in Surgery · 2021 - Present Surgery, Surgical Sciences, Surgery
Research Professor in Molecular Genetics and Microbiology · 2021 - Present Molecular Genetics and Microbiology, Basic Science Departments
Member of the Duke Human Vaccine Institute · 2009 - Present Duke Human Vaccine Institute, Institutes and Centers
Affiliate, Duke Global Health Institute · 2009 - Present Duke Global Health Institute, University Institutes and Centers

In the News


Published October 11, 2022
Federal Grant to Duke University School of Medicine Expands HIV Research
Published November 19, 2019
Global List of Highly Cited Puts Duke in Top Ten
Published November 27, 2018
Duke Faculty Plentiful On ‘Highly Cited’ List

View All News

Recent Publications


Computationally Selected Multivalent HIV-1 Subtype C Vaccine Protects Against Heterologous SHIV Challenge

Journal Article Vaccines · February 24, 2025 Background: The RV144 trial in Thailand is the only HIV-1 vaccine efficacy trial to date to demonstrate any efficacy. Genetic signatures suggested that antibodies targeting the variable loop 2 (V2) of the HIV-1 envelope played an important protecti ... Full text Cite

Rapid viral suppression using integrase inhibitors during acute HIV-1 infection.

Journal Article J Antimicrob Chemother · January 3, 2025 BACKGROUND: Antiretroviral therapy (ART) is recommended for all individuals with HIV infection, including those with acute HIV-1 infection (AHI). While recommendations are similar to those for chronic infection, efficacy data regarding treatment of acute H ... Full text Link to item Cite
View All Publications

Recent Grants


External Quality Assurance Program Oversight Laboratory (EQAPOL)

ResearchInvestigator · Awarded by National Institutes of Health · 2024 - 2031

HVTN Lab Center: B Cell Supplement

ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Center · 2023 - 2027

Synthetic DNA launched & adjuvanted Immune Focused Env immunogens for HIV

ResearchPrincipal Investigator · Awarded by Wistar Institute of Anatomy and Biology · 2022 - 2027

View All Grants

Education, Training & Certifications


University of Genoa (Italy) · 1985 M.D.